Insights

New CEO Appointment Syros Pharmaceuticals recently appointed Conley Chee as the new CEO, indicating potential strategic shifts or expansions that could lead to new business opportunities for partnerships or collaborations.

Clinical Data Launch The launch of clinical data from the Phase 1/1b trial of SY-5609 demonstrates the company's commitment to advancing treatments in the oncology space, presenting opportunities for discussions with healthcare providers and institutions.

Product Development With ongoing development of SY-2101, a new oral form of arsenic trioxide for APL treatment, Syros Pharmaceuticals showcases potential for entering new markets or engaging with distributors seeking innovative therapies.

Competitor Deal Termination The termination of the deal with Pfizer by Syros Pharmaceuticals hints at shifts in competitive positioning, opening doors for engaging with Pfizer competitors or exploring new avenues for partnerships within the industry.

Key Personnel Addition The addition of Dr. David A. Roth, a renowned clinical researcher and oncology drug developer, to the Syros Pharmaceuticals Board of Directors offers opportunities for leveraging his expertise to enhance current sales strategies or develop new market penetration tactics.

Syros Pharmaceuticals Tech Stack

Syros Pharmaceuticals uses 8 technology products and services including Google Analytics, Squarespace, Typekit, and more. Explore Syros Pharmaceuticals's tech stack below.

  • Google Analytics
    Analytics
  • Squarespace
    Content Management System
  • Typekit
    Font Scripts
  • Google Font API
    Font Scripts
  • Preact
    Javascript Libraries
  • RSS
    Miscellaneous
  • Apache
    Web Servers
  • Linkedin
    Widgets

Media & News

Syros Pharmaceuticals's Email Address Formats

Syros Pharmaceuticals uses at least 1 format(s):
Syros Pharmaceuticals Email FormatsExamplePercentage
fmlast@syros.comJMDoe@syros.com
25%
first.middle.last@syros.comJohn.Michael.Doe@syros.com
25%
flast@syros.comJDoe@syros.com
25%
lfirst@syros.comDJohn@syros.com
25%

Frequently Asked Questions

Where is Syros Pharmaceuticals's headquarters located?

Minus sign iconPlus sign icon
Syros Pharmaceuticals's main headquarters is located at 35 CambridgePark Drive 4th Floor Cambridge , MA 02140 US. The company has employees across 4 continents, including North AmericaEuropeAsia.

What is Syros Pharmaceuticals's phone number?

Minus sign iconPlus sign icon
You can contact Syros Pharmaceuticals's main corporate office by phone at +1-617-744-1340. For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Syros Pharmaceuticals's stock symbol?

Minus sign iconPlus sign icon
Syros Pharmaceuticals is a publicly traded company; the company's stock symbol is SYRS.

What is Syros Pharmaceuticals's official website and social media links?

Minus sign iconPlus sign icon
Syros Pharmaceuticals's official website is syros.com and has social profiles on LinkedIn.

How much revenue does Syros Pharmaceuticals generate?

Minus sign iconPlus sign icon
As of June 2024, Syros Pharmaceuticals's annual revenue reached $35M.

What is Syros Pharmaceuticals's SIC code NAICS code?

Minus sign iconPlus sign icon
Syros Pharmaceuticals's SIC code is 8731 - Commercial Physical and Biological Research NAICS code is 3254 - Pharmaceutical and Medicine Manufacturing.

How many employees does Syros Pharmaceuticals have currently?

Minus sign iconPlus sign icon
As of June 2024, Syros Pharmaceuticals has approximately 98 employees across 4 continents, including North AmericaEuropeAsia. Key team members include Chief Executive Officer: C. C.COO: K. K.Chief Business Officer & Chief Legal Officer: G. Q.. Explore Syros Pharmaceuticals's employee directory with LeadIQ.

What industry does Syros Pharmaceuticals belong to?

Minus sign iconPlus sign icon
Syros Pharmaceuticals operates in the Pharmaceutical Manufacturing industry.

What technology does Syros Pharmaceuticals use?

Minus sign iconPlus sign icon
Syros Pharmaceuticals's tech stack includes Google AnalyticsSquarespaceTypekitGoogle Font APIPreactRSSApacheLinkedin.

What is Syros Pharmaceuticals's email format?

Minus sign iconPlus sign icon
Syros Pharmaceuticals's email format typically follows the pattern of . Find more Syros Pharmaceuticals email formats with LeadIQ.

How much funding has Syros Pharmaceuticals raised to date?

Minus sign iconPlus sign icon
As of June 2024, Syros Pharmaceuticals has raised $45M in funding. The last funding round occurred on Dec 19, 2023.

When was Syros Pharmaceuticals founded?

Minus sign iconPlus sign icon
Syros Pharmaceuticals was founded in 2012.
Syros Pharmaceuticals

Syros Pharmaceuticals

Pharmaceutical ManufacturingMassachusetts, United States51-200 Employees

Syros is committed to developing new standards of care for the frontline treatment of patients with hematologic malignancies. Driven by the motivation to help patients with blood disorders that have largely eluded other targeted approaches, Syros is developing tamibarotene, an oral selective RARα agonist in frontline patients with higher-risk myelodysplastic syndrome and acute myeloid leukemia with RARA gene overexpression. For more information, visit www.syros.com and follow us on Twitter (@SyrosPharma) and LinkedIn.

Section iconCompany Overview

Headquarters
35 CambridgePark Drive 4th Floor Cambridge , MA 02140 US
Phone number
+1-617-744-1340
Website
syros.com
SIC Code
8731 - Commercial Physical and Biological Research
Stock Symbol
SYRS
NAICS Code
3254 - Pharmaceutical and Medicine Manufacturing
Founded
2012
Employees
51-200

Section iconFunding & Financials

  • $45M

    Syros Pharmaceuticals has raised a total of $45M of funding over 11 rounds. Their latest funding round was raised on Dec 19, 2023.

  • $10M$50M

    Syros Pharmaceuticals's revenue is in the range of $10M$50M

Section iconFunding & Financials

  • $45M

    Syros Pharmaceuticals has raised a total of $45M of funding over 11 rounds. Their latest funding round was raised on Dec 19, 2023.

  • $10M$50M

    Syros Pharmaceuticals's revenue is in the range of $10M$50M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.